A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab

Clinical trial NCT05583383 · UNKNOWN

Trial details

NCT number: NCT05583383
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Gastric Adenocarcinoma

Start date: 2022-03-31
Primary completion: 2025-03-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.